Fresh Meadows, New York Clinical Trials

A listing of Fresh Meadows, New York clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 272 clinical trials
Study of CPI-006 as Immunotherapy for Hospitalized COVID-19 Patients

This Phase 1 single-dose, dose-escalation study is an open label trial evaluating the safety of CPI-006, a humanized monoclonal antibody targeting the CD73 cell-surface ectonucleotidase, as immunotherapy for stable hospitalized mild or moderately symptomatic COVID-19 patients.

nasopharyngeal swab
SARS
cancer
monoclonal antibodies
nasal swab
Icahn School of Medicine at Mount Sinai
 (8.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +1 other locations
Personalized Second Chance Breast Conservation (PSCBC): A Two Center Prospective Phase II Clinical Study

The goal of the study is to investigate the feasibility of enabling a second chance for breast conservation in patients with in-breast recurrences after a previous lumpectomy and RT, investigators propose to test partial breast irradiation with the target volume encompassing the entire surgical bed with 1.0-1.5 cm margins.

lumpectomy
radiotherapy to breast
metastasis
invasive breast cancer
breast irradiation
Weill Cornell Medicine
 (8.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of CD19 Targeted CAR T Cell Therapy in Adult Patients With Relapsed or Refractory B Cell Acute Lymphoblastic Leukaemia (ALL)

This is a Phase Ib/II study to evaluate the safety and efficacy of autologous T cells engineered with a chimeric antigen receptor (CAR) targeting CD19 in adult patients with relapsed or refractory B cell acute lymphoblastic leukemia (ALL).

Memorial Sloan Kettering Cancer Center
 (8.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +29 other locations
Families Children and Teachers Thriving Together

The current study examines the impact of ParentCorps in high-poverty district schools in New York City (NYC). The study is conducted within the context of the NYC Department of Education (DOE) Pre-K Thrive initiative. As part of this initiative, the Center for Early Childhood Health and Development (CEHD) at NYU …

inspire
cehd
NYU Langone Health
 (9.7 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
manual trial test  

manual trial test overview

qa12
 (4.5 away)
  • 0 views
  • 19 Feb, 2024
  • +10 other locations
UAT Study

Bowen Test Study Overview

Formal Site
 (7.3 away) Contact site
  • 0 views
  • 09 May, 2025
  • +7 other locations
None

Memorial Sloan Kettering Cancer Center
 (8.9 away) Contact site
  • 0 views
  • 19 May, 2025
  • +19 other locations
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission - Josh McVoy  

The study will explore the effects of early intensive antiretroviral therapy (ART) with or without a broadly neutralizing antibody (bNAb) on achieving HIV remission (HIV RNA below the limit of detection of the assay) among infants living with HIV.

12001, Malawi Clinical Research Site
 (8.6 away)
  • 0 views
  • 24 Apr, 2026
  • +1 other locations
A Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine

The reason for this study is to see if lasmiditan is safe and effective in children aged 6 to 17 with migraine. The study will last up to 20 weeks and may include up to 4 visits.

treatment regimen
lasmiditan
migraine
headache
ly573144
Care Access Research - Bronx
 (8.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +162 other locations
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's Disease  

The purpose of this study is to evaluate the safety and efficacy of the ExAblate Model 4000 Type 2.0 System as a tool to disrupt the blood-brain barrier (BBB) in patients with probable Alzheimer's Disease (AD).

alzheimer's disease
Weill Cornell Medicine
 (8.9 away)
  • 0 views
  • 09 May, 2025
  • +2 other locations